DENVER, CO, Feb. 16 /PRNewswire-FirstCall/ -- Medical International Technology (MIT) Inc. (MDLH.OB) http://www.mitneedlefree.com/ is pleased to announce the publication of a major research report of its symbol MDLH by Grass Roots Research and Distribution, Inc. Grass Roots Research and Distribution, Inc reports that a unique product portfolio, superior technology and a proven business model are key growth drivers for Medical International Technology Inc. The report forecasts that the Company's Fiscal Year End (FYE) October 31, 2010 will grow to $2.3 million and to more than $100.9 million by FYE 2015. Grass Roots Research and Distribution, Inc, based on certain assumptions of the company's budget targets, expects Medical International Technology Inc. to represent an exciting long-term investment opportunity. For full report, please visit: http://www.cohenresearch.com/Images/107_02_15_2010.pdf "We are extremely pleased with this research report and its positive outlook on MIT's technology and potential growth" said Mr. Karim Menassa, President and CEO of Medical International Inc. "We firmly believe that our partnership and business relationship with China and other world markets will propel our revenue growth and increase shareholders value." Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system. About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individuals and mass vaccinations. The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements. DATASOURCE: MEDICAL INTERNATIONAL TECHNOLOGIES INC. CONTACT: Karim Menassa, President and CEO, (514) 339-9355; Harold Gervais, MBA, Vice-President and CFO, (514) 339-9355; Dr. Francis Bellido, PhD, MBA, Vice-President and Chief Strategy Officer, (514) 339-9355; ; http://www.mitneedlefree.com/

Copyright